Literature DB >> 25678887

Optogenetics and epilepsy: past, present and future.

Jeanne T Paz1, John R Huguenard2.   

Abstract

The holy grail of epilepsy research is to understand the mechanisms underlying seizures so that patients with epilepsy can receive effective treatment or be cured, ideally with no significant side effects. Recent advances in neuroscience give such hope. Optogenetics is a modern neuroscience research tool that allows precise spatiotemporal control of defined cells and circuits and, thus, dissection of critical players and targeting them for responsive treatments. Here we review the state of the art of these approaches and their applications and implications in epilepsy research.

Entities:  

Year:  2015        PMID: 25678887      PMCID: PMC4320957          DOI: 10.5698/1535-7597-15.1.34

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN: 1535-7511            Impact factor:   7.500


  29 in total

1.  Some cerebellar influences on electrically-induced cerebral seizures.

Authors:  P M COOKE; R S SNIDER
Journal:  Epilepsia       Date:  1955-11       Impact factor: 5.864

2.  Millisecond-timescale, genetically targeted optical control of neural activity.

Authors:  Edward S Boyden; Feng Zhang; Ernst Bamberg; Georg Nagel; Karl Deisseroth
Journal:  Nat Neurosci       Date:  2005-08-14       Impact factor: 24.884

3.  Multimodal fast optical interrogation of neural circuitry.

Authors:  Feng Zhang; Li-Ping Wang; Martin Brauner; Jana F Liewald; Kenneth Kay; Natalie Watzke; Phillip G Wood; Ernst Bamberg; Georg Nagel; Alexander Gottschalk; Karl Deisseroth
Journal:  Nature       Date:  2007-04-05       Impact factor: 49.962

4.  Selective photostimulation of genetically chARGed neurons.

Authors:  Boris V Zemelman; Georgia A Lee; Minna Ng; Gero Miesenböck
Journal:  Neuron       Date:  2002-01-03       Impact factor: 17.173

5.  Tetanus toxin as a tool for studying epilepsy.

Authors:  J Mellanby; C Hawkins; H Mellanby; J N Rawlins; M E Impey
Journal:  J Physiol (Paris)       Date:  1984

6.  Channelrhodopsin-2, a directly light-gated cation-selective membrane channel.

Authors:  Georg Nagel; Tanjef Szellas; Wolfram Huhn; Suneel Kateriya; Nona Adeishvili; Peter Berthold; Doris Ollig; Peter Hegemann; Ernst Bamberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-13       Impact factor: 11.205

7.  A high-light sensitivity optical neural silencer: development and application to optogenetic control of non-human primate cortex.

Authors:  Xue Han; Brian Y Chow; Huihui Zhou; Nathan C Klapoetke; Amy Chuong; Reza Rajimehr; Aimei Yang; Michael V Baratta; Jonathan Winkle; Robert Desimone; Edward S Boyden
Journal:  Front Syst Neurosci       Date:  2011-04-13

8.  ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation.

Authors:  John Y Lin; Per Magne Knutsen; Arnaud Muller; David Kleinfeld; Roger Y Tsien
Journal:  Nat Neurosci       Date:  2013-09-01       Impact factor: 24.884

9.  Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury.

Authors:  Jeanne T Paz; Thomas J Davidson; Eric S Frechette; Bruno Delord; Isabel Parada; Kathy Peng; Karl Deisseroth; John R Huguenard
Journal:  Nat Neurosci       Date:  2012-11-07       Impact factor: 24.884

10.  Optogenetic delay of status epilepticus onset in an in vivo rodent epilepsy model.

Authors:  Inna Sukhotinsky; Alexander M Chan; Omar J Ahmed; Vikram R Rao; Viviana Gradinaru; Charu Ramakrishnan; Karl Deisseroth; Ania K Majewska; Sydney S Cash
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

View more
  22 in total

1.  Implicating Interneurons: Optogenetic Studies Suggest That Interneurons Are Guilty of Contributing to Epileptiform Activity.

Authors:  Jamie L Maguire
Journal:  Epilepsy Curr       Date:  2015 Jul-Aug       Impact factor: 7.500

2.  Illuminating the Cerebellum as a Potential Target for Treating Epilepsy.

Authors:  Jennifer C Wong; Andrew Escayg
Journal:  Epilepsy Curr       Date:  2015 Sep-Oct       Impact factor: 7.500

Review 3.  Optogenetic tools for modulating and probing the epileptic network.

Authors:  Mingrui Zhao; Rose Alleva; Hongtao Ma; Andy G S Daniel; Theodore H Schwartz
Journal:  Epilepsy Res       Date:  2015-06-21       Impact factor: 3.045

4.  Investigation of Seizure-Susceptibility in a Drosophila melanogaster Model of Human Epilepsy with Optogenetic Stimulation.

Authors:  Arunesh Saras; Veronica V Wu; Harlan J Brawer; Mark A Tanouye
Journal:  Genetics       Date:  2017-06-19       Impact factor: 4.562

5.  Minimal time spiking in various ChR2-controlled neuron models.

Authors:  Vincent Renault; Michèle Thieullen; Emmanuel Trélat
Journal:  J Math Biol       Date:  2017-06-29       Impact factor: 2.259

Review 6.  Optogenetics: the new molecular approach to control functions of neural cells in epilepsy, depression and tumors of the central nervous system.

Authors:  Bruno Camporeze; Bruno Alcântara Manica; Gabriel Alves Bonafé; Jivago Jordão Camargos Ferreira; Aurélio Lourenço Diniz; Carlos Tadeu Parisi de Oliveira; Luis Roberto Mathias Junior; Paulo Henrique Pires de Aguiar; Manoela Marques Ortega
Journal:  Am J Cancer Res       Date:  2018-10-01       Impact factor: 6.166

Review 7.  Involvement of cortical fast-spiking parvalbumin-positive basket cells in epilepsy.

Authors:  X Jiang; M Lachance; E Rossignol
Journal:  Prog Brain Res       Date:  2016-06-07       Impact factor: 2.453

8.  Illuminating the Role for Chloride Dysregulation in Network Activity.

Authors:  Akshay Gupta; Viji Santhakumar
Journal:  Epilepsy Curr       Date:  2016 Jul-Aug       Impact factor: 7.500

9.  The antiepileptic and ictogenic effects of optogenetic neurostimulation of PV-expressing interneurons.

Authors:  Fadi Assaf; Yitzhak Schiller
Journal:  J Neurophysiol       Date:  2016-07-13       Impact factor: 2.714

Review 10.  Optogenetic Approaches for Controlling Seizure Activity.

Authors:  Jack K Tung; Ken Berglund; Robert E Gross
Journal:  Brain Stimul       Date:  2016-07-14       Impact factor: 8.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.